BCL2 inhibitor ABT-199
ABT-199(venetoclax, RG7601, GDC-0199) is a new selective small molecule inhibitor of BCL-2 that appears to spare platelets while achieving potent antitumor activity.
Mar 25，2025 API
Side effects of afatinib dimaleate
Afatinib dimaleate, the dimaleate form of afatinib, is an orally bioavailable anilinoquinazoline derivative that is an inhibitor of the epidermal growth factor receptor (ErbB; EGFR) family of receptor
Mar 25，2025 API
Dextrin Unveiled: From Basic Concepts to Gluten
Dextrins are a category that includes several different carbohydrate strains that are produced by the hydrolysis of starch.
Mar 25，2025 Supplements
2,2'-Dithiosalicylic acid: Synthesis and Identification
2,2'-Dithiosalicylic Acid is used as an intermediate for the synthesis of pharmaceuticals, dyes, photochemicals (thioxanthones) and biocides (proxel).
Mar 25，2025 Chemical Materials
Does Pralsetinib need to be reduced in patients with liver impairment?
Pralsetinib is a kinase inhibitor used to treat metastatic rearranged during transfection (RET) fusion-positive non-small cell lung cancer.
Mar 25，2025 Biochemical Engineering
Application Research of n-Heptadecane
n-Heptadecane is widely used in many fields due to its unique properties, such as cleaning agents, fuel additives, etc.
Mar 25，2025 Chemical Materials
Sulfadoxine: Uses, Safety, and Resistance
Sulfadoxine is predominantly used in combination with pyrimethamine, commonly known as Fansidar, for the treatment of Plasmodium falciparum.
Mar 25，2025 API
Relugolix: Development Background and Mechanism of Action
Relugolix is ??a GnRH antagonist, or gonadotropin-releasing hormone receptor antagonist, used to treat prostate cancer in men and uterine fibroids in women.
Mar 24，2025 Biochemical Engineering
What is the use of lenvatinib mesylate?
Lenvatinib mesylate, a first-line anticancer agent for the treatment of unresectable hepatocellular carcinoma, is a BCS class II drug with low aqueous solubility.
Mar 24，2025 API
Function and mechanism of action of Fisetin in cancer
Fisetin has been shown to inhibit invasion and migration of various types of cancer cells.
Mar 24，2025 API